ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Kane Biotech Inc

Kane Biotech Inc (KNE)

0.145
0.005
(3.57%)
Closed July 23 4:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.145
Bid
0.14
Ask
0.15
Volume
53,961
0.145 Day's Range 0.145
0.05 52 Week Range 0.17
Market Cap
Previous Close
0.14
Open
0.145
Last Trade
41500
@
0.145
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
74,867
Shares Outstanding
131,844,000
Dividend Yield
-
PE Ratio
-3.50
Earnings Per Share (EPS)
-0.04
Revenue
2.82M
Net Profit
-5.27M

About Kane Biotech Inc

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Headquarters
Winnipeg, Manitoba, Can
Founded
1970
Kane Biotech Inc is listed in the Coml Physical, Biologcl Resh sector of the TSX Venture Exchange with ticker KNE. The last closing price for Kane Biotech was $0.14. Over the last year, Kane Biotech shares have traded in a share price range of $ 0.05 to $ 0.17.

Kane Biotech currently has 131,844,000 shares outstanding. The market capitalization of Kane Biotech is $18.46 million. Kane Biotech has a price to earnings ratio (PE ratio) of -3.50.

KNE Latest News

Kane Biotech Receives FDA Approval to Increase Dosage Allowance of its revyve™ Antimicrobial Wound Gel

WINNIPEG, Manitoba, July 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that the US Food and Drug Administration...

Kane Biotech Receives ISO 13485:2016 MDSAP Quality Certification

WINNIPEG, Manitoba, July 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has received ISO 13485:2016 Medical Device Single...

Kane Biotech Announces Issuance of Restricted Share Units

WINNIPEG, Manitoba, July 15, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announces that it has issued 4,213,133 restricted share...

Kane Biotech Signs Worldwide License Agreement with Omni Bioceutical Innovations Inc.

WINNIPEG, Manitoba, July 11, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has signed a worldwide license agreement with...

Kane Biotech Makes First Commercial Sale of revyve™ Antimicrobial Wound Gel to ProgenaCare Global

WINNIPEG, Manitoba, June 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has made its first commercial-scale sale of...

Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.

WINNIPEG, Manitoba, June 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has entered into a worldwide license agreement with...

Kane Biotech Announces First Quarter 2024 Financial Results

WINNIPEG, Manitoba, May 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces its first quarter 2024 financial results. The...

Kane Biotech to Release First Quarter 2024 Financial Results on May 23, 2024

WINNIPEG, Manitoba, May 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development...

Kane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound Map

WINNIPEG, Manitoba, May 15, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces its intent to commercialize the patented...

Kane Biotech to Host Investor Webinar

WINNIPEG, Manitoba, April 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane”) announces that it will be hosting a webinar on Thursday April 18th, 2024 at 4:15pm...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.005-3.333333333330.150.150.135181000.13696133CS
40.0053.571428571430.140.170.135437980.14723406CS
120.017.407407407410.1350.170.115748670.13787308CS
260.05561.11111111110.090.170.0751306820.12612923CS
520.0670.58823529410.0850.170.05846700.11515514CS
156-0.035-19.44444444440.180.190.05638430.11541618CS
2600.02520.83333333330.120.260.05675010.13553836CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NUZENuZee Inc
$ 1.91
(85.44%)
1.94M
NIVFNewGenIvf Group Ltd
$ 1.27
(45.83%)
4.62M
ALLRAllarity Therapeutics Inc
$ 0.242
(45.35%)
42M
SLNASelina Hospitality PLC
$ 0.0307
(18.08%)
47.53M
DRMADermata Therapeutics Inc
$ 1.51
(16.15%)
112.24k
VSTMVerastem Inc
$ 2.65
(-26.18%)
437.24k
IONMAssure Holdings Corporation
$ 1.86
(-23.46%)
63.83k
SLRXSalarius Pharmaceuticals Inc
$ 2.18
(-16.48%)
230.14k
ALPPAlpine 4 Holdings Inc
$ 0.5039
(-16.00%)
305.27k
TSLRGraniteShares ETF Trust GraniteShares
$ 17.53
(-15.52%)
202.41k
SLNASelina Hospitality PLC
$ 0.0307
(18.08%)
47.53M
ALLRAllarity Therapeutics Inc
$ 0.242
(45.35%)
42M
TSLATesla Inc
$ 227.52
(-7.65%)
18.09M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 11.62
(-15.18%)
16.79M
HOLOMicroCloud Hologram Inc
$ 0.58
(-0.82%)
9.6M

KNE Discussion

View Posts
teq0904 teq0904 7 months ago
They have been making about 2,500 samples per month in their lab for distribution to doctors for more than a month. By the time the contract plant starts up at the end of March there will be over 10k samples out so lots of doctors will be familiar with the product. You can bet they went to the burn centers and other of their top identified markets first.
👍️0
teq0904 teq0904 9 months ago
Latest video on kne
https://www.facebook.com/KaneBiotechInc/videos/292568703569665
👍️0
teq0904 teq0904 11 months ago
cc on Tuesday
👍️0
teq0904 teq0904 11 months ago
Doesn't matter what you think the dog market is, because it will be sold. Strategic review nr.
👍️0
teq0904 teq0904 11 months ago
First closing of the financing is probably next week. Officers and directors are in on it.
👍️0
teq0904 teq0904 12 months ago
On the previous cc, Edwards said it is possible that the FDA will approve the manufacturing plant in time for the sales to start in Q4.
👍️0
teq0904 teq0904 12 months ago
The next quarterly cc will be late in August.
👍️0
teq0904 teq0904 12 months ago
The next step is for the outsourced manufacturing of coactiv+ to be completed. It may already be done, but it was supposed to take 3 months after receiving FDA approval.
👍️0
teq0904 teq0904 12 months ago
They have FDA approval for coactiv+.
👍️0
J_Dean J_Dean 3 years ago
This is the year. Let’s go! :)
👍️0
Golden Cross Golden Cross 4 years ago
Kane Biotech Announces Third Quarter 2019
Financial Results

https://backend.otcmarkets.com/otcapi/company/dns/news/document/40388/content
👍️0
Golden Cross Golden Cross 4 years ago
KNBIF Website:

https://www.kanebiotech.com/
👍️0
Golden Cross Golden Cross 4 years ago
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (56 patents and patents pending, trade secrets and trademarks) and products developed by the Company’s own biofilm research expertise and acquired from leading research institutions. StrixNBTM, DispersinB®, Aledex®, bluestemTM, AloSeraTM, coactiv+TM and Kane® are trademarks of Kane Biotech Inc. The Company is listed on the TSX Venture Exchange under the symbol "KNE".
👍️0
Golden Cross Golden Cross 4 years ago
Monster # of filings today $KNBIF

https://www.otcmarkets.com/stock/KNBIF/disclosure
👍️0
sfld sfld 4 years ago
This might pump this week. Mentioned in a National Inflation Association newsletter today. GLTA
👍️0
pegcitygreen pegcitygreen 5 years ago
I live in Winnipeg and have personally worked with this company. Great people, great products, but the company itself always seems to struggle. Kane products are for wealthy/well off people who love their pets and more than likely do not have any kids. A very, very niche market. Their tradeshows booth is quite impressive...but that doesn't mean impressive sales.
👍️0
teq0904 teq0904 5 years ago
CEO got 2M shares in the market now.
👍️0
teq0904 teq0904 5 years ago
Jan 30 cc and presentation shows the potential markets. Just sign into it and you end up with the archive. https://edge.media-server.com/m6/p/rzpqebyy
👍️0
Macaveli Macaveli 6 years ago
Decent news released today. Plus insiders are buying. This is a hidden gem.
👍️0
teq0904 teq0904 6 years ago
Sales are slow for this startup, however the products are superb so I imagine it will be a good company in the long run. I used the oral rinse and shampoo for my dog. I don't know if the rinse is the reason, but the vet told me this month that her teeth are in excellent shape for her age.
She also had a bad itch last winter and scratched day and night. It didn't stop with the use of a vet's prescription shampoo, so I tried the Kane product with excellent results. As soon as I put it on her she stops scratching for about 1 day, so I just apply it once daily wherever I see her scratching.

I know a guy who had terrible psoriasis itching on the scalp all day and night long but it all stopped when he used the human shampoo.
👍️0

Your Recent History

Delayed Upgrade Clock